CoLink Cfx Plating System

K200762 · In2bones USA, LLC · HRS · Apr 23, 2020 · Orthopedic

Device Facts

Record IDK200762
Device NameCoLink Cfx Plating System
ApplicantIn2bones USA, LLC
Product CodeHRS · Orthopedic
Decision DateApr 23, 2020
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic, Pediatric

Intended Use

The In2Bones USA LLC, CoLink® Cfx System is indicated for stabilization of fractures, revision procedures, osteotomies and reconstruction of the small bones in the foot and ankle including the calcaneus in both pediatric and adult patients.

Device Story

CoLink® Cfx Plating System consists of metallic plates and screws for orthopedic fixation; used for stabilization of calcaneal fractures, osteotomies, and reconstruction. System components are made of titanium alloy; provided sterile. Device is used in clinical settings by orthopedic surgeons. Output is physical stabilization of bone segments. Clinical benefit includes bone fracture healing and structural reconstruction. System utilizes previously cleared screws (K181113, K170518, K180377) and plates similar in geometry to predicate systems.

Clinical Evidence

No clinical data. Performance supported by engineering analysis and bench testing. Four-point bend testing performed per ASTM F382. Bacterial endotoxin testing (LAL) performed on each lot. Sterilization, biocompatibility, and shelf-life validations adopted from previously cleared CoLink® Afx System (K181113).

Technological Characteristics

Metallic bone fixation system (plates and screws). Material: Titanium alloy. Standards: ASTM F382 (four-point bend testing). Provided sterile. No electronic or software components.

Indications for Use

Indicated for stabilization/fixation of fractures, revision procedures, osteotomies, and reconstruction of small bones in the foot and ankle, including the calcaneus, in pediatric and adult patients.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the date April 23, 2020. The text is written in a simple, sans-serif font. The date is written in the standard US format, with the month first, followed by the day and year. The text is black and the background is white. In2Bones USA, LLC Christine Scifert VP of Quality and Regulatory 6000 Poplar Ave. Suite 115 Memphis, Tennessee 38119 Re: K200762 Trade/Device Name: CoLink Cfx Plating System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: March 23, 2020 Received: March 24, 2020 Dear Christine Scifert: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Shumaya Ali, MPH Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health {2}------------------------------------------------ # Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below. 510(k) Number (if known) K200762 Device Name CoLink® Cfx Plating System Indications for Use (Describe) The In2Bones USA LLC, CoLink® Cfx System is indicated for stabilization of fractures, revision procedures, osteotomies and reconstruction of the small bones in the foot and ankle including the calcaneus in both pediatric and adult patients. Type of Use (Select one or both, as applicable) | <div> <span> <svg height="12" width="12"> <rect fill="lightgray" height="12" stroke="black" width="12"></rect> <path d="M2,2 L10,10 M2,10 L10,2" stroke="black"></path> </svg> </span> Prescription Use (Part 21 CFR 801 Subpart D) </div> | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | <div> <span> <svg height="12" width="12"> <rect fill="white" height="12" stroke="black" width="12"></rect> </svg> </span> Over-The-Counter Use (21 CFR 801 Subpart C) </div> | ## CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # 510(k) Summary CoLink® Cfx Plating System April 10, 2020 | Company: | In2Bones USA, LLC<br>6000 Poplar Ave, Suite 115<br>Memphis, TN 38119<br>901-260-7931 | |--------------------|-------------------------------------------------------------------------------------------| | Primary Contact: | Christine Scifert | | Company Contact: | Rebecca Wahl | | Trade Name: | CoLink® Cfx Plating System | | Common Name: | Plate, Fixation, Bone<br>Screw, Fixation, Bone | | Classification: | II | | Regulation Number: | 888.3030 - Single/multiple component metallic bone fixation appliances<br>and accessories | | Panel: | 87-Orthopedic | | Product Code(s): | HRS, HWC | The In2Bones CoLink® Cfx Plating System is a system of plates and screws and Device Description: surgical instruments intended for stabilization of calcaneal fractures and osteotomies. These subject devices are part of the overarching CoLink® Plating System and will be commonly referred to as the CoLink® Cfx Plating System. Indications for Use: The In2Bones USA LLC, CoLink® Cfx System is indicated for stabilization and fixation of fractures, revision procedures, osteotomies and reconstruction of the small bones in the foot and ankle including the calcaneus in both pediatric and adult patients. Substantial Equivalence: The subject components were demonstrated to be substantially equivalent to the following systems previously cleared by the FDA: {4}------------------------------------------------ Primary Predicate - K163293 In2Bones CoLink® Plating System . Additional Predicates - K182148 – Paragon 28 Silverback Gorilla Plating System - K181113 In2Bones CoLink® Afx Plating System ● Similar to the primary predicate device (K163293), the subject CoLink® Cfx Plating System is made of Titanium Alloy and provided sterile. The CoLink® Cfx Plating System has similar indications to the CoLink® Plating System (K163293) and Silverback Gorilla Plating System (K182148). This submission is adding additional plates for the calcaneus that will be used with previously cleared screws. The 3.5mm and 4.0mm screws initially cleared in the CoLink® Afx Plating System (K181113) can be used with the CoLink® Cfx Plating System. The previously cleared CoLag® screws (K170518 and K180377) that are intended to be used as stand-alone screws can also be used during the procedure with the CoLink® Cfx Plating System, but would not be used in conjunction with the plates or screws. The subject plates and screws have been demonstrated to be substantially equivalent to the previously cleared devices identified above as the products are similar in indications, materials and geometry. Performance Testing: No additional mechanical testing was required for the CoLink® Cfx Plating System. The 3.5mm and 4.0mm screws are identical to previously cleared screws and no new worst-case plates were added. Engineering analysis was conducted related to the CoLink® Plating four-point bend testing performed per ASTM F382 to show the subject plates are substantially equivalent to the predicate plates. The CoLink® Cfx Plating System is not a worst case for sterilization, biocompatibility, shelf life and pyrogenicity and was adopted into the previous validations for the CoLink® Afx System (K181113). Bacterial endotoxin testing (LAL) is performed on each lot. ## Conclusion Based on the test results and the comparison to the predicate devices, the subject device is determined to be substantially equivalent to the predicate devices.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%